Company: CGCT
Filing Date: 2025-04-14
Form Type: S-1/A
Source: 0001104659-25-034635
Chunk: 135

Company: Cartesian Growth Corp III
Filing Date: 2025-04-14
Form: S-1/A
Chunk 135
---
 the holder as a result of owning private placement warrants or public warrants or otherwise) relative to all
of our shares outstanding both before and after the redemption. If such redemption is not treated as a sale of Class A ordinary
shares for U.S. federal income tax purposes, the redemption will instead be treated as a corporate distribution of cash from us.
For more information about the U.S. federal income tax treatment of the redemption of Class A ordinary shares, see the sections
entitled “Certain Income Tax Considerations — United States Federal Income Tax Considerations — U.S. Holders — Redemption of Class A Ordinary Shares” or “Certain Income Tax Considerations — United States Federal Income Tax Considerations — Non-U.S. Holders,” as applicable.

We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then-outstanding public warrants. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of Class A ordinary shares purchasable upon exercise of a warrant could be decreased, all without your approval.

Our warrants will be issued in registered form
under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement
provides that the terms of the warrants may be amended without the consent of any holder for the purpose of (i) curing any ambiguity
or to correct any defective provision or mistake, including to conform the provisions of the warrant agreement to the description of
the terms of the warrants and the warrant agreement set forth in this prospectus, (ii) adjusting the provisions relating to cash
dividends on ordinary shares as contemplated by and in accordance with the warrant agreement, (iii) adding or changing any provisions
with respect to matters or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or
desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants or (iv) to provide
for the delivery of the Alternative Issuance (as defined in the section of this prospectus captioned “Description of Securities — Warrants — Public Warrants”), provided that the approval by the holders of at least 50% of the then-outstanding public warrants is required to
make any change that adversely affects the interests of the registered holders of public warrants. Accordingly, we may amend the terms
of the public warrants in a manner adverse to a